Keeping our community going strong for 10 years
A few weeks ago, Katherine Wilemon reminded me that the FH Foundation (now the Family Heart Foundation) was soon to have our 10-year anniversary.
Whoa! Mind blowing!
While I was not there at the exact inception of the FH Foundation, I have been along … Read More →
Today, 23andMe announced a new Genetic Health Risk Report for Familial Hypercholesterolemia.
Now, individuals who are 23andMe Health+ Ancestry service customers will be alerted if they have one of 24 of the more common gene variants for Familial Hypercholesterolemia (FH) that can be analyzed. Since … Read More →
The results of the ODYSSEY Outcomes trial of Alirocumab (Praluent) were presented today at the American College of Cardiology Scientific sessions. Alirocumab is an injectable antibody PCSK9 inhibitor that has been shown to significantly reduce LDL-cholesterol levels in prior trials.
ODYSSEY Background
ODYSSEY … Read More →
